Employees: 02 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 1994-01-01 (32 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CONQUES-EN-ROUERGUE (12320), Aveyron
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SOCIETE PHARMACIE PARET : revenue, balance sheet and financial ratios
SOCIETE PHARMACIE PARET is a French company
founded 32 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CONQUES-EN-ROUERGUE (12320),
this company of category PME
shows in 2022 a revenue of 1.6 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SOCIETE PHARMACIE PARET (SIREN 393798095)
Indicator
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
1 567 977 €
N/C
N/C
N/C
N/C
N/C
N/C
Net income
52 255 €
83 183 €
62 443 €
42 040 €
32 615 €
18 013 €
15 064 €
9 968 €
EBITDA
N/C
84 061 €
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
5.3%
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2023, SOCIETE PHARMACIE PARET generates positive net income of 52 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2023: 10 k€ -> 52 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
52 255 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 20%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 72%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
20.143%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
72.0%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
Debt ratio
0.0
0.0
0.0
12.542
9.81
7.037
4.415
20.143
Financial autonomy
87.741
84.11
82.454
71.602
72.332
71.119
72.522
72.0
Repayment capacity
None
None
None
None
None
None
0.379
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
5.383%
None%
Sector positioning
Debt ratio
20.142023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Excellent
In 2023, the debt ratio of SOCIETE PHARMACIE PARET (20.14) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
72.0%2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Excellent
In 2023, the financial autonomy of SOCIETE PHARMACIE PARET (72.0%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
0.38 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Excellent
In 2022, the repayment capacity of SOCIETE PHARMACIE PARET (0.38) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 237.85. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
Liquidity ratio
152.713
140.919
140.847
140.323
137.558
137.311
142.553
237.852
Interest coverage
None
None
None
None
None
None
0.27
None
Sector positioning
Liquidity ratio
237.852023
2021
2022
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Good+40 pts over 3 years
In 2023, the liquidity ratio of SOCIETE PHARMACIE PARET (237.85) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
0.27x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Average
In 2022, the interest coverage of SOCIETE PHARMACIE PARET (0.3x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2023)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2023)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2023)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2023)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SOCIETE PHARMACIE PARET
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
Operating WCR
0 €
0 €
0 €
0 €
0 €
0 €
-35 844 €
0 €
Inventory turnover (days)
0
0
0
0
0
0
21
0
Customer payment term (days)
0
0
0
0
0
0
5
0
Supplier payment term (days)
0
0
0
0
0
0
15
0
Positioning of SOCIETE PHARMACIE PARET in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of SOCIETE PHARMACIE PARET is estimated at
616 581 €
(range 374 972€ - 866 775€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
374k€616k€866k€
616 581 €Range: 374 972€ - 866 775€
NAF 5 année 2023
Valuation method used
Net Income Multiple
52 255 €
×
11.8x
=616 582 €
Range: 374 973€ - 866 775€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SOCIETE PHARMACIE PARET with other companies in the same sector:
Frequently asked questions about SOCIETE PHARMACIE PARET
What is the revenue of SOCIETE PHARMACIE PARET ?
The revenue of SOCIETE PHARMACIE PARET in 2022 is 1.6 M€.
Is SOCIETE PHARMACIE PARET profitable?
Yes, SOCIETE PHARMACIE PARET generated a net profit of 52 k€ in 2023.
Where is the headquarters of SOCIETE PHARMACIE PARET ?
The headquarters of SOCIETE PHARMACIE PARET is located in CONQUES-EN-ROUERGUE (12320), in the department Aveyron.
Where to find the tax return of SOCIETE PHARMACIE PARET ?
The tax return of SOCIETE PHARMACIE PARET is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SOCIETE PHARMACIE PARET operate?
SOCIETE PHARMACIE PARET operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart